Xeolas Pharmaceuticals

Mental health stigma remains a major barrier to treatment and recovery, leading to discrimination, social exclusion, and worsening mental health issues. In September, we came together during Green Ribbon Month, showing support and solidarity with those facing mental health challenges. Wearing the Green Ribbon was the first step toward breaking the stigma, but the work doesn’t stop there. Let’s continue encouraging open conversations, supporting one another, and sharing resources to create a truly empathetic and caring environment. Together, we can make a lasting impact. #SeeChange #BreakTheStigma #MentalHealthAwareness

We're proud to announce that our new Baldoyle manufacturing site has been authorised by the HPRA following a recent GMP Inspection. Our 150,000 sq. ft. facility is authorised for the manufacture of finished products and investigational products according to EU-GMP. The Xeolas team has done an amazing job to prepare the facility to meet our ambitious plans and maintain the highest quality standards. A special thank you to our incredible team. This accomplishment wouldn’t have been possible without your hard work, dedication, and collaboration. As we look ahead, we're excited to build on this milestone and continue driving innovation in healthcare. #HPRAAuthorised

Today, September 25th, is World Pharmacists Day. It is a day to recognise the vital role pharmacists play in meeting global health needs. At Xeolas, we are proud to contribute to this mission by researching, developing, and commercialising innovative medicines that address unmet medical needs. In doing so, we help improve treatment adherence and patient outcomes worldwide. Together, we strive to support patients, healthcare professionals, and the broader community by ensuring access to safe and effective treatments. #WorldPharmacistsDay

We are committed to fostering a positive and supportive work environment. Earlier this year, we had a fantastic time celebrating IBEC’s Workplace Wellbeing Day for the second year in a row. Our team enjoyed online coaching sessions, a refreshing lunchtime walk, and delicious healthy snacks and lunch. These activities weren’t just about promoting a happy and healthy workplace; they also encouraged interaction across departments, fostered connections, and strengthened our community. We’re already looking forward to the next one! #WorkplaceWellbeing #EmployeeWellbeing

We’re thrilled to announce that our team will be attending CPHI Milan this October. Contact us to arrange a meeting with Andrew Broderick (Commercial Director), Dennis McDaid (Technical Director) or Dolores Lynch (Operations Director), and discover Xeolas' cutting-edge solutions addressing unmet patient needs. We’re looking forward to making connections, meeting industry professionals, and gaining fresh insights. Let’s connect and drive innovation forward! #CPHIMilan2024

Are you curious about life at Xeolas? Here at Xeolas, we are on a mission to create medicines that put patients with medical needs first. We are currently a team of 75 dedicated individuals driven by innovation, ambition, quality and teamwork, supporting each other every step of the way. Together, we work to make a positive impact in the healthcare field. Check out this testimonial from one of our team members, we invite you to visit our career page and discover what our team has to say: https://lnkd.in/ehrYjE-J #Xeolas #EmployeeTestimonial

At Xeolas, we are experts in researching, developing, and manufacturing stable and effective complex formulation solutions. Here’s why they are a game-changer: - Versatile and patient-friendly option for medication delivery, especially for those with swallowing difficulties. - Enhanced stability: Perfect for challenging drugs and biopharmaceutics. - Flexible dosing: Allows for individualised treatment plans, optimising therapeutic efficacy. Our patented technologies ensure innovative and reliable solutions for better patient outcomes. #Xeolas #Pharmaceuticals #PatientCare #ComplexFormulations #DrugDevelopment

Take a behind-the-scenes look at our manufacturing facility. Here, our dedicated team works together to develop and produce high-quality products destined to be distributed globally, ultimately making a difference in patient’s lives. From formulation to clinical testing to regulatory submission, we're committed to efficiency and excellence every step of the way. #Xeolas #Manufacturing #BehindTheScenes #Quality #PatientFriendlyMedicines

Today, we would like to introduce a pivotal concept that drives Xeolas: Unmet Medical Needs (UMN). Discover why this concept is incredibly important to us. UMN is a widely used term with no universal definition in healthcare. It generally refers to gaps present in available therapies or non-existent treatments for managing certain diseases and conditions. For us, it is crucial to understand and address UMN. We prioritise identifying those gaps in the current healthcare landscape. We strive to develop safe, effective and tailored treatment options that can better meet the unique requirements of patients. It can improve health outcomes, enhance quality of life and provide much-needed support for patients and their caregivers. Keen to learn more about how we're making a difference in addressing Unmet Medical Needs (UMN) in healthcare? Dive deeper into our website to explore our approach and ongoing initiatives. Click here to discover more: https://lnkd.in/gXmn9M7J #Xeolas #UMN #Healthcare #PatientFriendlyMedicines

In this post, we proudly want to give you a sneak peek into what makes Xeolas special. At our core, you will discover a blend of innovation, quality, ambition and teamwork. These values aren’t just words, they are the driving force behind everything we do. #Xeolas #Values #Culture #Innovation #Ambition #Quality #Teamwork